Torrent Pharmaceuticals is currently trading at Rs. 485.50, up by 5.60 points or 1.17% from its previous closing of Rs. 479.90 on the BSE.
The scrip opened at Rs. 482.50 and has touched a high and low of Rs. 493.00 and Rs. 480.00 respectively. So far 16337 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 5 has touched a 52 week high of Rs. 521.00 on 13-Dec-2013 and a 52 week low of Rs. 328.00 on 15-Mar-2013.
Last one week high and low of the scrip stood at Rs. 495.00 and Rs. 466.50 respectively. The current market cap of the company is Rs. 8291.07 crore.
The promoters holding in the company stood at 71.51% while Institutions and Non-Institutions held 16.81% and 11.68% respectively.
Torrent Pharmaceuticals has received US Food and Drug Administration (US FDA) approval for Epilepsy drug Lamotrigine, a medicine which is used in partial epilepsy, bipolar disorder, generalised epilepsy, Lennox-Gastaut syndrome and absence seizures.
Torrent Pharmaceuticals is flagship company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1817.20 |
Dr. Reddys Lab | 1344.50 |
Cipla | 1476.20 |
Lupin | 2163.85 |
Zydus Lifesciences | 973.55 |
View more.. |